Immatics Interest Expense from 2010 to 2025

IMTXW Stock  USD 0.03  0.01  23.60%   
Immatics Biotechnologies Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense will likely drop to about 907.9 K in 2025. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2018-03-31
Previous Quarter
226 K
Current Value
235 K
Quarterly Volatility
1.5 M
 
Covid
Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 15.7 M or Interest Income of 16.7 M, as well as many indicators such as Price To Sales Ratio of 15.53, Dividend Yield of 0.0 or PTB Ratio of 3.22. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Immatics Biotechnologies Correlation against competitors.

Latest Immatics Biotechnologies' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of immatics biotechnologies GmbH over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Immatics Biotechnologies' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
170.289.1.7M8.3M831.955.907.70%497%380%-90%15%-5%100%
       Timeline  

Immatics Interest Expense Regression Statistics

Arithmetic Mean831,407
Geometric Mean93,613
Coefficient Of Variation246.50
Mean Deviation1,067,861
Median16,000
Standard Deviation2,049,453
Sample Variance4.2T
Range8.3M
R-Value0.42
Mean Square Error3.7T
R-Squared0.18
Significance0.11
Slope180,474
Total Sum of Squares63T

Immatics Interest Expense History

2025907.9 K
2024955.6 K
2023831 K
20228.3 M
20211.7 M
2020289 K
2019170 K

About Immatics Biotechnologies Financial Statements

Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense955.6 K907.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immatics Stock Analysis

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.

Trending Assets

ATNFW
CannBioRx Life Sciences
0.01  -0.0006  -5.66 
ARTLW
Artelo Biosciences
0.00  0.00  0.00 
IMACW
IMAC Holdings
0.00  0.00  0.00 
BCDAW
BioCardia
0.00  0.00  0.00 
ENTXW
Entera Bio
0.00  0.00  0.00 
News Freq…Investor S…